Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhen Fan Yang

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Gastroenterology and Hepatology|August 9, 2002
Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transferSiu Tim Cheung, Tung Yu Tsui, Wei Lin Wang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 31, 2007
Induction of long-term liver allograft survival by delayed immunosuppression is dependent on interleukin-10Zhen Fan Yang, Patricia Ngai, Chi Keung Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cellsChi Keung Lau, Zhen Fan Yang, David W Ho, et al.
Molecular Cancer Therapeutics|September 21, 2006
High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesisZhen Fan Yang, Ronnie T P Poon, Yuqing Liu, et al.
Cancer Research|January 25, 2005
Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinomaZhen Fan Yang, David W Ho, Chi Tat Lam, et al.
Cancer Biology & Therapy|December 7, 2007
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinomaChi Keung Lau, Zhen Fan Yang, Shuk Pik Lam, et al.
Oncology Reports|November 8, 2006
Significance of the serum brain-derived neurotrophic factor and platelets in hepatocellular carcinomaZhen Fan Yang, David W Ho, Chi Keung Lau, et al.
Cancer|May 19, 2006
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinomaDavid Wing Yuen Ho, Zhen Fan Yang, Birgitta Yee-Hang Wong, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathwayXiao Qi Wang, Weg M Ongkeko, Lin Chen, et al.
International Journal of Cancer|October 6, 2005
Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinomaChing Tung Lum, Zhen Fan Yang, Hoi Yee Li, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Gastroenterology and Hepatology|August 9, 2002
Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transferSiu Tim Cheung, Tung Yu Tsui, Wei Lin Wang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 31, 2007
Induction of long-term liver allograft survival by delayed immunosuppression is dependent on interleukin-10Zhen Fan Yang, Patricia Ngai, Chi Keung Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cellsChi Keung Lau, Zhen Fan Yang, David W Ho, et al.
Molecular Cancer Therapeutics|September 21, 2006
High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesisZhen Fan Yang, Ronnie T P Poon, Yuqing Liu, et al.
Cancer Research|January 25, 2005
Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinomaZhen Fan Yang, David W Ho, Chi Tat Lam, et al.
Cancer Biology & Therapy|December 7, 2007
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinomaChi Keung Lau, Zhen Fan Yang, Shuk Pik Lam, et al.
Oncology Reports|November 8, 2006
Significance of the serum brain-derived neurotrophic factor and platelets in hepatocellular carcinomaZhen Fan Yang, David W Ho, Chi Keung Lau, et al.
Cancer|May 19, 2006
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinomaDavid Wing Yuen Ho, Zhen Fan Yang, Birgitta Yee-Hang Wong, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathwayXiao Qi Wang, Weg M Ongkeko, Lin Chen, et al.
International Journal of Cancer|October 6, 2005
Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinomaChing Tung Lum, Zhen Fan Yang, Hoi Yee Li, et al.
Pageof 4